{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:08:48Z","timestamp":1649160528319},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biosci"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12038-014-9428-x","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T05:48:20Z","timestamp":1398836900000},"page":"505-512","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The rare intracellular RET mutation p.S891A in a Chinese Han family with familial medullary thyroid carcinoma"],"prefix":"10.1007","volume":"39","author":[{"given":"Xiao-Ping","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Lin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang-Yang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren-Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"9428_CR1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1590\/S0004-27302012000800021","volume":"56","author":"CB Blom","year":"2012","unstructured":"Blom CB, Ceolin L, Romitti M, Siqueira D and Maia AL 2012 The rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literature. Arq. Bras. Endocrinol. Metabol. 56 586\u2013591","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"9428_CR2","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, et al. 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 86 5658\u20135671","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9428_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0929-6646(09)60084-X","volume":"108","author":"CF Chang","year":"2009","unstructured":"Chang CF, Yang WS, Su YN, Wu IL and Chang TC 2009 Mutational Spectrum of Multiple EndocrineNeoplasia Type 2 and Sporadic Medullary Thyroid Carcinoma in Taiwan. J. Formos. Med. Assoc. 108 402\u2013408","journal-title":"J. Formos. Med. Assoc."},{"key":"9428_CR4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB and Compton CC 2010 The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17 1471\u20131474","journal-title":"Ann. Surg. Oncol."},{"key":"9428_CR5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","volume":"97","author":"R Elisei","year":"2012","unstructured":"Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, Agate L, Cappagli V, Miccoli P, et al. 2012 The timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center. J. Clin. Endocrinol. Metab. 97 426\u2013435","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9428_CR6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, et al. 1996 The relationship between specific RET protooncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276 1575\u20131579","journal-title":"JAMA"},{"key":"9428_CR7","doi-asserted-by":"crossref","unstructured":"Figlioli G, Landi S, Romei C, Elisei R and Gemignani F 2013 Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat. Res. 752 36\u201344","DOI":"10.1016\/j.mrrev.2012.09.002"},{"key":"9428_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/humu.9161","volume":"22","author":"G Fitze","year":"2003","unstructured":"Fitze G, Schierz M, Kuhlisch E, Schreiber M, Ziegler A, Roesner D and Schackert HK 2003 Novel Intronic Polymorphisms in the RET Protooncogene and Their Association With Hirschsprung Disease. Hum. Mutat. 22 177","journal-title":"Hum. Mutat."},{"key":"9428_CR9","doi-asserted-by":"crossref","unstructured":"Fugazzola L, De Leo S and Perrino M 2013 The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association. Thyroid Res. 6 S8","DOI":"10.1186\/1756-6614-6-S1-S8"},{"key":"9428_CR10","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","volume":"83","author":"SA Hundahl","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM and Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985\u20131995 [see comments]. Cancer 83 2638\u20132648","journal-title":"Cancer"},{"key":"9428_CR11","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1038\/sj.onc.1202742","volume":"18","author":"T Iwashita","year":"1999","unstructured":"Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajita H and Takahashi M 1999 Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene 18 3919\u20133922","journal-title":"Oncogene"},{"key":"9428_CR12","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1756-6614-6-S1-S9","volume":"6","author":"B Jarzab","year":"2013","unstructured":"Jarzab B, Szpak-Ulczok S, Wloch J, Czarniecka A and Krajewska J 2013 Timing and criteria for prophylactic thyroidectomy in asymptomatic RET mutation carriers-the role of Ct serum level. Thyroid Res. 6 S9","journal-title":"Thyroid Res"},{"key":"9428_CR13","doi-asserted-by":"crossref","unstructured":"Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G and Gagel RF 2004 Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J. Clin. Endocrinol. Metab. 89 4142\u20134145","DOI":"10.1210\/jc.2004-0041"},{"key":"9428_CR14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jamcollsurg.2004.12.011","volume":"200","author":"E Kebebew","year":"2005","unstructured":"Kebebew E, Greenspan FS, Clark OH, Woeber KA and Grunwell J 2005 Extent of disease and practice patterns for medullary thyroid cancer. J. Am. Coll. Surg. 200 890\u2013896","journal-title":"J. Am. Coll. Surg."},{"key":"9428_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD,Schlumberger M and Wells SA Jr 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19 565\u2013612","journal-title":"Thyroid"},{"key":"9428_CR16","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/ijc.27967","volume":"132","author":"F Lantieri","year":"2013","unstructured":"Lantieri F, Caroli F, Ceccherini I and Griseri P 2013 The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study. Int. J. Cancer 132 2808\u20132819","journal-title":"Int. J. Cancer"},{"key":"9428_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2007.03153.x","volume":"69","author":"A Machens","year":"2008","unstructured":"Machens A and Dralle H 2008 Familial prevalence and age of RET germline mutations: Implications for screening. Clin. Endocrinol. 69 81\u201387","journal-title":"Clin. Endocrinol."},{"key":"9428_CR18","doi-asserted-by":"crossref","unstructured":"Machens A, Lorenz K and Dralle H 2009 Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities. J. Intern. Med. 266 114\u2013125.","DOI":"10.1111\/j.1365-2796.2009.02113.x"},{"key":"9428_CR19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, et al. 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363 458\u2013460","journal-title":"Nature"},{"key":"9428_CR20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1242\/dev.119.4.1005","volume":"119","author":"V Pachnis","year":"1993","unstructured":"Pachnis V, Mankoo B and Costantini F 1993 Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119 1005\u20131017","journal-title":"Development"},{"key":"9428_CR21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/07357900701518735","volume":"25","author":"Z Paszko","year":"2007","unstructured":"Paszko Z, Sromek M, Czetwertynska M, Skasko E, Czapczak D, Wisniewska A, Prokurat A, Chrupek M, Jagielska A and Kozlowicz-Gudzinska I 2007 The occurrence and the type of germline mutations in the RET Gene in Patients with medullary thyroid carcinoma and their unaffected kindred\u2019s from central Poland. Cancer Invest. 25 742\u2013749","journal-title":"Cancer Invest."},{"key":"9428_CR22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1158\/0008-5472.CAN-04-2363","volume":"65","author":"I Plaza Menacho","year":"2005","unstructured":"Plaza Menacho I, Koster R, van der Sloot AM, Quax WJ, Osinga J, van der Sluis T, Hollema H, Burzynski GM, Gimm O, Buys CH, Eggen BJ and Hofstra RM 2005 RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src\/JAK\/STAT3 pathway, independent of glial cell line-derived neurotrophic factor. Cancer Res. 65 1729\u20131737","journal-title":"Cancer Res."},{"key":"9428_CR23","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/thy.2012.0134","volume":"22","author":"XP Qi","year":"2012","unstructured":"Qi XP, Chen XL, Ma JM, Du ZF, Fei J, Yang CP, Cheng J, Song QZ, et al. 2012 RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China. Thyroid 22 1257\u20131265","journal-title":"Thyroid"},{"key":"9428_CR24","doi-asserted-by":"crossref","first-page":"e20353","DOI":"10.1371\/journal.pone.0020353","volume":"6","author":"XP Qi","year":"2011","unstructured":"Qi XP, Ma JM, Du ZF, Ying RB, Fei J, Jin HY, Han JS, Wang JQ, et al. 2011 RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A\/Familial medullary thyroid carcinoma Family. PLoS One 6 e20353","journal-title":"PLoS One"},{"key":"9428_CR25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejso.2013.06.015","volume":"39","author":"XP Qi","year":"2013","unstructured":"Qi XP, Zhao JQ, Du ZF, Yang RR, Ma JM, Fei J, Cheng J, Han JS, Jin HY, et al. 2013 Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China. Eur. J. Surg. Oncol. 39 1007\u20131012","journal-title":"Eur. J. Surg. Oncol."},{"key":"9428_CR26","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","volume":"107","author":"S Roman","year":"2006","unstructured":"Roman S, Lin R and Sosa JA 2006 Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer 107 2134\u20132142","journal-title":"Cancer"},{"key":"9428_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/367377a0","volume":"367","author":"G Romeo","year":"1994","unstructured":"Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, et al. 1994 Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung\u2019s disease. Nature 367 377\u2013378","journal-title":"Nature"},{"key":"9428_CR28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1677\/ERC-08-0098","volume":"15","author":"GH Sakorafas","year":"2008","unstructured":"Sakorafas GH, Friess H and Peros G 2008 The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy. Endocr. Relat. Cancer 15 871\u2013884","journal-title":"Endocr. Relat. Cancer"},{"key":"9428_CR29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s10038-006-0064-7","volume":"51","author":"S Sangkhathat","year":"2006","unstructured":"Sangkhathat S, Kusafuka T, Chengkriwate P, Patrapinyokul S, Sangthong B and Fukuzawa M 2006 Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. J. Hum. Genet. 51 1126\u20131132","journal-title":"J. Hum. Genet."},{"key":"9428_CR30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3322\/caac.21195","volume":"64","author":"DF Schneider","year":"2013","unstructured":"Schneider DF and Chen H 2013 New Developments in the Diagnosis and Treatment of Thyroid Cancer. CA Cancer J. Clin. 64 373\u2013394","journal-title":"CA Cancer J. Clin."},{"key":"9428_CR31","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1210\/jc.2010-0375","volume":"95","author":"KM Schulte","year":"2010","unstructured":"Schulte KM, Machens A, Fugazzola L, McGregor A, Diaz-Cano S, Izatt L, Aylwin S, Talat N, Beck-Peccoz P and Dralle H 2010 The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A. J. Clin. Endocrinol. Metab. 95 E92 -97","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9428_CR32","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1089\/thy.2005.15.1267","volume":"15","author":"H Vierhapper","year":"2005","unstructured":"Vierhapper H, Niederle B, Bieglmayer C, Kaserer K and Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15 1267\u20131272","journal-title":"Thyroid"},{"key":"9428_CR33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1530\/ERC-13-0082","volume":"20","author":"VB Virtanen","year":"2013","unstructured":"Virtanen VB Pukkala E, Kivisaari R, Salo PP, Koivusalo A, Arola J, Miettinen PJ, Rintala RJ, Perola M and Pakarinen MP 2013 Thyroid cancer and co-occurring RET mutations in Hirschsprung disease. Endocr. Relat. Cancer 20 595\u2013602","journal-title":"Endocr. Relat. Cancer"},{"key":"9428_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6061\/clinics\/2012(Sup01)14","volume":"67","author":"SM Wagner","year":"2012","unstructured":"Wagner SM, Zhu S, Nicolescu AC and Mulligan LM 2012 Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2. Clinics (Sao Paulo) 67 77\u201384","journal-title":"Clinics (Sao Paulo)"},{"key":"9428_CR35","doi-asserted-by":"crossref","unstructured":"Wells SA Jr, Pacini F, Robinson BG and Santoro M 2013 Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update. J. Clin. Endocrinol. Metab. 98 3149\u20133164","DOI":"10.1210\/jc.2013-1204"}],"container-title":["Journal of Biosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12038-014-9428-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12038-014-9428-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12038-014-9428-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T14:59:16Z","timestamp":1648911556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12038-014-9428-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["9428"],"URL":"https:\/\/doi.org\/10.1007\/s12038-014-9428-x","relation":{},"ISSN":["0250-5991","0973-7138"],"issn-type":[{"value":"0250-5991","type":"print"},{"value":"0973-7138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}